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Abstract 
Background 
Animal production workers are persistently exposed to organic dust and can suffer from a variety of 
respiratory disease symptoms and annual decline in lung function. The role of high mobility group box-1 
(HMGB1) in inflammatory airway diseases is emerging. Hence, we tested a hypothesis that organic dust 
exposure of airway epithelial cells induces nucleocytoplasmic translocation of HMGB1 and blocking this 
translocation dampens organic dust-induced lung inflammation. 
Methods 
Rats were exposed to either ambient air or swine barn (8 h/day for either 1, 5, or 20 days) and lung tissues 
were processed for immunohistochemistry. Swine barn dust was collected and organic dust extract 
(ODE) was prepared and sterilized. Human airway epithelial cell line (BEAS-2B) was exposed to either 
media or organic dust extract followed by treatment with media or ethyl pyruvate (EP) or anti-HMGB1 
antibody. Immunoblotting, ELISA and other assays were performed at 0 (control), 6, 24 and 48 h. Data (as 
mean ± SEM) was analyzed using one or two-way ANOVA followed by Bonferroni’s post hoc comparison 
test. A p value of less than 0.05 was considered significant. 
Results 
Compared to controls, barn exposed rats showed an increase in the expression of HMGB1 in the lungs. 
Compared to controls, ODE exposed BEAS-2B cells showed nucleocytoplasmic translocation of HMGB1, 
co-localization of HMGB1 and RAGE, reactive species and pro-inflammatory cytokine production. EP 
treatment reduced the ODE induced nucleocytoplasmic translocation of HMGB1, HMGB1 expression in 
the cytoplasmic fraction, GM-CSF and IL-1β production and augmented the production of TGF-β1 and 
IL-10. Anti-HMGB1 treatment reduced ODE-induced NF-κB p65 expression, IL-6, ROS and RNS but 
augmented TGF-β1 and IL-10 levels. 
Conclusions 
HMGB1-RAGE signaling is an attractive target to abrogate OD-induced lung inflammation. 
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Ethyl pyruvate reduces organic
dust-induced airway inflammation by
targeting HMGB1-RAGE signaling
Sanjana Mahadev Bhat1, Nyzil Massey1, Locke A. Karriker2, Baljit Singh3 and Chandrashekhar Charavaryamath1*
Abstract
Background: Animal production workers are persistently exposed to organic dust and can suffer from a variety of
respiratory disease symptoms and annual decline in lung function. The role of high mobility group box-1 (HMGB1)
in inflammatory airway diseases is emerging. Hence, we tested a hypothesis that organic dust exposure of airway
epithelial cells induces nucleocytoplasmic translocation of HMGB1 and blocking this translocation dampens organic
dust-induced lung inflammation.
Methods: Rats were exposed to either ambient air or swine barn (8 h/day for either 1, 5, or 20 days) and lung
tissues were processed for immunohistochemistry. Swine barn dust was collected and organic dust extract (ODE)
was prepared and sterilized. Human airway epithelial cell line (BEAS-2B) was exposed to either media or organic
dust extract followed by treatment with media or ethyl pyruvate (EP) or anti-HMGB1 antibody. Immunoblotting,
ELISA and other assays were performed at 0 (control), 6, 24 and 48 h. Data (as mean ± SEM) was analyzed using
one or two-way ANOVA followed by Bonferroni’s post hoc comparison test. A p value of less than 0.05 was
considered significant.
Results: Compared to controls, barn exposed rats showed an increase in the expression of HMGB1 in the lungs.
Compared to controls, ODE exposed BEAS-2B cells showed nucleocytoplasmic translocation of HMGB1, co-localization
of HMGB1 and RAGE, reactive species and pro-inflammatory cytokine production. EP treatment reduced the ODE
induced nucleocytoplasmic translocation of HMGB1, HMGB1 expression in the cytoplasmic fraction, GM-CSF and IL-1β
production and augmented the production of TGF-β1 and IL-10. Anti-HMGB1 treatment reduced ODE-induced NF-κB
p65 expression, IL-6, ROS and RNS but augmented TGF-β1 and IL-10 levels.
Conclusions: HMGB1-RAGE signaling is an attractive target to abrogate OD-induced lung inflammation.
Keywords: Organic dust, HMGB1, RAGE, Lung inflammation, Ethyl pyruvate
Background
Globally agriculture employs about 1.3 billion people [1]
and in the US, about 1.8 million people work in the agri-
culture industry. However, agriculture is considered a dan-
gerous profession due to significant number of deaths,
injuries and morbidities (reviewed in [2]). People who work
in agriculture and other related industries are persistently
exposed to many contaminants and suffer from respiratory
diseases and other conditions (reviewed in [2, 3]). Among
the occupational contaminants, persistent exposure to
organic dust (OD) is central to the negative health effects
of work-related exposures. OD is a complex mixture of
particulate matter of varying sizes, microbes and microbial
products [4]. Workers from concentrated animal feeding
operations (CAFOs) involved in swine, diary [5] and
poultry production including duck hatcheries [6] (reviewed
in [2]) as well as other industries (sewage handlers, waste
handlers and bakery workers) are persistently exposed to
the OD.
In North America, more than one million men, women
and children suffer from exposure to OD [7]. There is a
strong link between exposure to OD and development of
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inflammatory airway diseases and annual decline in lung
function (reviewed in [8, 9]). Individuals exposed to OD
report a range of respiratory and other symptoms includ-
ing bronchitis, chest tightness, nasal congestion, organic
dust toxic syndrome, occupational asthma, mucus mem-
brane irritation, nausea, headache, mood changes, altered
immunity [10–12], and increased risks of lung cancer [13].
Presence of multiple microbial and non-microbial factors
in OD and broad-range of health effects upon exposure
are a significant public health concern. Currently, there
are limited therapeutic options to treat OD-induced in-
flammatory airway diseases.
OD exposure induced respiratory symptoms and
long-term changes in lung function are a major occupa-
tional health issue in swine production workers (reviewed
in [2, 4]). Previously, experimental exposure of human vol-
unteers to swine barn environment indicated an underlying
inflammatory process [14]. We employed a unique rat
model mimicking human occupational exposure to swine
barn environment and showed that single 8 h exposure in-
duces airway inflammation and reactivity. In the same
model, multiple (5 and 20-day) exposures resulted in damp-
ened airway inflammation and reactivity. Surprisingly, there
was an increase in the number of mucus producing goblet
cells in the airways and activation of bronchus-associated
lymphoid tissue (BALT) following 20-day exposure [15].
Mechanisms leading to the development of these airway re-
modeling features despite dampened inflammation and air-
way reactivity with 20-day exposure remain elusive.
Next, using wild type or tlr4 mutant mouse, we demon-
strated that barn exposure-induced lung inflammation,
but not airway reactivity, is dependent on TLR4. In the
same model, we documented airway epithelial damage in
a TLR4-independent manner [16]. Subsequently, the roles
of TLR9 [17], TLR2 [18], NOD2 [19], MyD88 [20], and
protein kinase C epsilon (PKC ε) in organic dust-induced
airway inflammation have been demonstrated. OD expos-
ure has also been linked to bone loss indicating the sys-
temic effects of exposure [21] (reviewed in [22]). These
studies and our previous work (reviewed in [2]) demon-
strate that OD is complex in composition and inhaled OD
elicits host response through multiple signaling pathways.
Despite increased understanding of mechanisms of OD-
induced lung inflammation, therapeutic options to treat
OD-induced lung diseases are limited.
Damage associated molecular patterns (DAMPs) are en-
dogenous molecules that are released upon tissue damage
[23]. DAMPs are increasingly becoming important in
chronic airway diseases [24]. High-mobility group box 1
(HMGB1) is a prototype DAMP present in almost all nu-
cleated cells. HMGB1 is a normal nuclear protein that
upon translocation to cytoplasm and secretion into extra-
cellular milieu behaves as a DAMP with inflammatory
cytokine-like properties (reviewed in [25, 26]). Immune
activation or necrosis is known to cause nucleocytoplasmic
translocation and release of HMGB1 into extra-cellular
space in many inflammatory airway diseases [24, 26].
HMGB1 is known to play a pathogenic role in asthma with
contributions to airway smooth muscle (ASM) dysfunction
and airway reactivity [27]. Blocking HMGB1 has been
beneficial in a mouse model of allergic airway disease and
sepsis [28, 29].
Post-translational modifications such as phosphorylation
and acetylation determine the nucleocytoplasmic transloca-
tion, secretion and pathogenic role of secreted HMGB1
[30, 31]. Nucleocytoplasmic translocation of HMGB1 in-
volves JAK-STAT1 mediated acetylation of lysine residues
on nuclear localization sites (NLS) whereas pyroptosis or
exocytosis of secretory lysosomes leads to secretion of
HMGB1 into extracellular milieu (reviewed in [32]). Several
tools such as JAK/STAT1 inhibitor [33], sirtuin 1 [34],
anti-HMGB1 antibodies [35] and ethyl pyruvate [36] have
been used to abrogate the pathological effects of HMGB1.
We tested a hypothesis that OD exposure of airway epi-
thelial cells induces translocation of HMGB1 and blocking
HMGB1 translocation dampens OD-induced lung inflam-
mation. In the current study, using a human airway epi-
thelial cell line (BEAS-2B) model, we demonstrate that
OD-exposure induces nucleocytoplasmic translocation of
HMGB1 and inflammation. Further, we show that EP or
anti-HMGB1 treatment reduces OD-induced airway in-
flammation via blocking HMGB1 translocation and signal-
ing through secreted HMGB1 respectively.
Methods
Rats and organic dust exposure
Rat model of organic dust exposure has previously been
described [15]. Rat exposure to the swine barn environ-
ment (organic dust exposure) was conducted with ap-
proved protocols from University of Saskatchewan
Campus Committee on Animal Care. All the animal ex-
periments were performed as per the Canadian Council on
Animal Care Guidelines. Six-week-old, male, Sprague-
Dawley rats (n = 5/group, Charles River Laboratories) were
exposed to either ambient air (control) or one, five or
20-days to swine barn environment (8 h/day). At the end
of the exposure period, rats were euthanized, lung tissues
were collected and processed for immunohistochemistry
[15]. The paraformaldehyde-fixed, paraffin-embedded tis-
sues from these rats were used in the current study.
Immunohistochemical analysis
Immunohistochemistry on five-micron thick tissue sections
(n = 5 rats/group) was performed using anti-HMGB1
(1:1000, Abcam) and HRP (1:1000, ant-rabbit IgG; Abcam)
and counterstained with methyl green (Vector Laboratories,
Inc., Burlingame, CA). An investigator blinded to the treat-
ment groups semi-quantified the cell specific expression of
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HMGB1 in bronchioles, endothelium of blood vessels, al-
veolar septa, ASM and bronchus associated lymphoid tissue
(BALT) using predetermined scoring criteria (outlined in
Table 1). Scored regions were photographed (Nikon Eclipse
TE2000-U; Spot Advance imaging software, Michigan,
USA).
Organic dust extract preparation
Settled dust samples from typical swine housing facilities
(representing organic dust) were collected into zip lock
bags and transported on ice and stored at − 80 °C until
processed. A sterile organic dust extract was prepared as
per a published protocol [37]. Dust samples were weighed
and for every gram of dust, 10mL of Hanks’ balanced salt
solution without calcium (Gibco) was added, stirred and
allowed to stand at room temperature for an hour. The
mixture was centrifuged (1365 x g, 4 °C) for 20min, super-
natant recovered, and pellet was discarded. Supernatant
was centrifuged again with same conditions, pellet dis-
carded and recovered supernatant was filtered using
0.22 μm filter and stored at − 80 °C until used. The filter
sterilized organic dust extract (ODE) samples were con-
sidered 100% and diluted to 1–5% (v/v) before use in
experiments.
Endotoxin estimation
The levels of endotoxin in the ODE samples was quanti-
fied using the Pyrochrome® chromogenic endotoxin assay
kit (Associates of Cape Cod, Inc., East Falmouth, MA).
The ODE samples were diluted in a ratio of 1:10 in endo-
toxin free water. The samples along with reconstituted
pyrochrome lysate, were added to a 96-well plate in a sam-
ple to lysate ratio of 1:4. The standard was reconstituted
as per manufacturer’s recommendation and added to the
plate in a sample to lysate ratio of 1:4. The microplate was
incubated at 37 °C with shaking and the absorbance was
read at 405 nm (every 10min, three readings over a total
of 30min) using the Gen 5™ software in BioTek® ELx808™
spectrophotometer.
Cell culture and treatments
Immortalized human bronchial epithelial cells
(BEAS-2B, ATCC CRL-9609) have previously been used
to study innate inflammatory responses to ODE [38, 39].
BEAS-2B cells were seeded onto type I bovine collagen
(StemCell Technologies, Vancouver, BC, Canada) coated
T-75 flasks. Cells were grown submerged in serum free
LHC-9 medium (Gibco) containing 100 U/mL of Penicil-
lin/Streptomycin (Gibco) and 2 μg/mL of Amphotericin
B (Sigma) in a humidified chamber with 5% CO2 at 37 °
C until approximately 80% confluence was achieved.
Ethyl pyruvate (EP, Santa Cruz Biotechnology, CA) was
reconstituted in Ringer’s solution (Sigma-Aldrich, St. Louis,
MO, USA) and used at a final concentration of 2.5 μM in
the cell culture medium (Fig. 1). Neutralization of secreted
HMGB1 was carried out using anti-HMGB1 antibody
(BioLegend, CA) at a concentration of 10 μg/mL [40].
Our in vitro model of ODE exposure and treatments
are represented (Fig. 1 a and b). Cells were treated with
either medium (control) or lipopolysaccharide (LPS,
Escherichia coli O127:B8; Sigma) or peptidoglycan
(PGN, Staphylococcus aureus; Sigma), or ODE (1–5% v/
v) (treatment 1, Fig. 1) followed by a co-treatment with
either medium or EP (treatment 2, Fig. 1a) or anti-
HMGB1 neutralizing antibody (treatment 2, Fig. 1b).
Following treatment, 1 and 2, samples were processed at
0, 6, 24 and 48 h for various assays. For NF-κB p65 assays,
samples were collected at 15 and 30min as well as 1, 1.5,
2 and 3 h. Control samples did not differ at various time
points (6, 24 and 48 h) and hence controls samples at 0 h
were included for all data analysis.
LPS and PGN were used as standard pathogen associ-
ated molecular patterns (PAMPs) (data not shown).
Table 2 summarizes the stock and working concentra-
tions of various PAMPs used in treatment 1 (Fig. 1)
prepared by dissolving in LHC-9 medium from stock
concentrations.
Cell viability assay
Prior to conducting experiments, cell viability was assessed.
Live/dead cell count was determined by 4% trypan blue
dye (EMD Millipore, Burlington, MA) exclusion and per-
centage viability was calculated. Population of cells with
more than 95% viability were used for the experiments.
Immunofluorescence microscopy
Cells were seeded (1 × 106 cells/well) in 12-well plates
on Poly D-lysine hydro bromide (Sigma-Aldrich, St.
Louis, MO) coated cover slips and exposed to the
treatments as outlined in Fig. 1. Cells were fixed with
4% paraformaldehyde in PBS for 20 min at room
temperature and washed. Cells were blocked for an
hour using a blocking buffer containing 10% normal
donkey serum (EMD Millipore, Burlington, MA), 0.2%
triton X 100 and PBS. Cover slips with cells were incu-
bated with anti-HMGB1 (1:1000 dilution, rabbit
Table 1 Semi-quantitative evaluation of HMGB1 expression and
criteria for sassigning scores
Score Criteria
0 No expression
1 Minimal
2 Mild
3 Moderate
4 Intense
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polyclonal) and anti-RAGE (1:200 dilution, rabbit poly-
clonal) antibodies in antibody diluent solution (2.5%
normal donkey serum, 0.25% sodium azide, 0.2% triton
X 100, PBS) (AbCam, Cambridge, MA) with overnight
at 4 °C. Next, coverslips were incubated with donkey
anti-rabbit biotin conjugated secondary antibody
(1:400, diluted in antibody diluent, HMGB1) and 1:500
dilutions of FITC (RAGE) (Jackson Immunoresearch,
West Grove, PA) for an hour at room temperature,
followed by streptavidin-Cy3 (1:300 in PBS,
HMGB1). Coverslips were mounted onto slides using
VECTASHIELD antifade mounting medium with
Fig. 1 ODE exposure of BEAS-2B cells and EP or anti-HMGB1 neutralizing antibody treatment. BEAS-2B cells were treated with either media (control)
or ODE (treatment 1) followed by either media, EP (a, treatment-2) or neutralizing HMGB1 antibody (b, treatment 2). Cells were processed for various
assays at 0 (control), 6, 24 and 48 h by collecting cells on coverslips or cell pellet or cell supernatant
Table 2 Stock and working concentrations of cell treatments
Treatments Stock concentration
(in cell culture grade water)
Working concentration
(in LHC-9)
LPS 5 mg/mL 10 μg/mL
PGN 1mg/mL 10 μg/mL
ODE 100% 1–5%
Table 3 Primer sequences used for qRT-PCR
Gene Symbol Primer Sequence (5′→ 3′)
nfκbp65 Forward CCAGACCAACAACAACCCCT
Reverse TCACTCGGCAGATCTTGAGC
nfκbp50 Forward GCAGCACTACTTCTTGACCACC
Reverse TCTGCTCCTGAGCATTGACGTC
nfκbp52 Forward GGCAGACCAGTGTCATTGAGCA
Reverse CAGCAGAAAGCTCACCACACTC
relB Forward TGTGGTGAGGATCTGCTTCCAG
Reverse TCGGCAAATCCGCAGCTCTGAT
crel Forward AGTTGCGGAGACCTTCTGACCA
Reverse CGTGATCCTGGCACAGTTTCTG
tlr2 Forward CTTCACTCAGGAGCAGCAAGCA
Reverse ACACCAGTGCTGTCCTGTGACA
tlr4 Forward CCCTGAGGCATTTAGGCAGCTA
Reverse AGGTAGAGAGGTGGCTTAGGCT
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4′,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI,
Vector Labs, Burlingame, CA) and imaged using Axiovert
200M Zeiss inverted fluorescence microscope (Zeiss,
Deutschland, Germany) equipped with Hamamatsu cam-
era. Images were processed using HCImage live 4 software
(Hamamatsu Corporation, Sewickley, PA).
Fig. 2 OD exposure of rats in the swine barn work environment and HMGB1 expression. Immunohistochemical staining for HMGB1 expression was
performed on rat lung tissues. Compared to controls, one, five and 20-day barn (organic dust) exposure of rats induced an increase in the expression of
HMGB1 in the bronchioles, alveolar septa and BALT (a) and endothelium of the blood vessels and ASM (arrows and inset, bar = 100 μm, e), respectively.
One-way ANOVA performed on immunohistochemical scores for HMGB1 expression in bronchioles (9 fields/animal), alveolar septa (5 fields/animal) and
BALT (7 fields/animal) (b-d) and endothelium of blood vessels (3 fields/animal) and ASM (11 fields/animal) is presented (f and g). *p< 0.05, **p< 0.005,
***p< 0.0005, ****p< 0.0001
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Western blot analysis
Cells were harvested followed by separation of cytoplasmic
and nuclear fractions using NE-PER nuclear and cytoplas-
mic extraction kit supplemented with a mixture of protease
and phosphatase inhibitors (Thermo Scientific, USA). For
NF-κB p65 detection, whole cell lysates were used as well.
Total protein levels were estimated by Bradford assay and
equal amounts of protein (20 μg/sample), along with a
molecular weight marker (Bio-Rad, Hercules, CA), were
loaded on to 12% Tris-glycine gels (Bio-Rad, Hercules, CA).
The gels were subjected to 100V for 1–2 h at 4 °C. Next,
proteins were transferred on to a nitrocellulose membrane at
23V at 4 °C for 16 h. Membranes were washed once with
distilled water and non-specific binding was blocked with
fluorescent western blot blocking buffer (Rockland Immuno-
chemicals, PA, USA) in PBS at room temperature for an
hour. Membranes were washed twice with 1X PBS with
0.05% tween 20 (PBST) and incubated with primary rabbit
monoclonal anti-HMGB1 antibody (1:1000 dilution) or
rabbit polyclonal anti-NF-κB p65 antibody (1:1000 dilution),
mouse polyclonal anti-β-Actin (1:6000) and rabbit polyclonal
anti-Lamin B1 (1:1000) (AbCam, Cambridge, MA) anti-
bodies overnight at 4 °C. β-actin (whole cell lysate and cyto-
plasmic fractions) and Lamin-B1 (nuclear fraction) were
used as loading controls. Membranes were then washed and
incubated with goat anti-mouse and donkey anti-rabbit IgG
P680 (1:10,000 dilution) secondary antibody (Thermo-Scien-
tific, USA). Membranes were scanned using the Odyssey®
CLx IR imaging system (LI-COR Biotechnology, Lincoln,
NE) and analysis was performed using ImageJ program (Na-
tional Institute of Health).
Measurement of reactive oxygen species
Intracellular reactive oxygen species (ROS) production
was measured using chloromethyl derivative of
dichlorodihydrofluorescein diacetate (CM-H2DCFDA)
(ThermoFisher Scientific, USA). A working solution of
10 μM of DCFDA in PBS was used. BEAS-2B cells
(5 × 104/well) were seeded in a 96 well cell culture
plate and incubated in a 5% CO2 incubator to reach
confluence. The cells were incubated with H2DCFDA
working solution at 37 °C for 30 min, followed by
treatments as outlined in Fig. 1. The fluorescence in-
tensity of the oxidized form of H2DCFDA was mea-
sured at excitation/emission wavelengths of 488/535
nm (SpectraMax M2 Gemini Molecular Device Micro-
plate Reader). The results were expressed as percent-
age fluorescence relative to control.
Griess assay
Griess assay was performed as described [41]. Briefly,
nitric oxide secretion was measured (representing re-
active nitrogen species (RNS)) as nitrite levels in cell
culture media using Griess reagent (Sigma) and so-
dium nitrite standard curve, prepared using a stock
solution of 200 μM. The assay was performed in a 96
well-plate and absorbance was measured at 550 nm
(SpectraMax M2 Gemini Molecular Device Microplate
Reader). The results were expressed as μM concentra-
tion of nitrite secreted.
Cytokine analysis
GM-CSF, IL-1β, IL-8, IL-6, IL-10 and TGF-β1 levels in
BEAS-2B cell culture supernatant were measured using
ELISA kits (ThermoFisher Scientific, USA) in accord-
ance with the manufacturer’s recommendations.
qRT-PCR
RNA was isolated using TRIzol extraction methods
[42] and RNA concentration was measured using
NanoDrop spectrophotometer. Two micrograms of
RNA was used to synthesize cDNA using the Super-
script III first strand synthesis kit (ThermoFisher
Scientific, USA) following the manufacturer’s protocol.
For qPCR reactions, 5 μL of SYBR Green Mastermix
(ThermoFisher Scientific, USA), 1 μL of primers, 1–
2 μL of water and 1–2 μL of cDNA was used. The
primers for genes of interest (Table 3) were synthesized at
Iowa State University’s DNA Facility. The housekeeping
gene 18 S rRNA (ThermoFisher Scientific, USA) was used
in all qPCR reactions. No-template controls and dissoci-
ation curves were run for all reactions to exclude
cross-contamination. The qRT-PCR reactions were run in a
Bio-Rad CFX Connect™ detection system and the data was
analyzed using 2-ΔΔCT method [43].
Statistical analysis
Data were expressed as mean ± SEM and analyzed by
one-way or two-way ANOVA followed by Bonferroni’s
post hoc comparison tests (GraphPad Prism 7.0, La Jolla,
CA, USA). A p-value of < 0.05 was considered statisti-
cally significant.
Results
Barn exposure and HMGB1 expression in the lungs
Using immunohistochemistry, we delineated cell spe-
cific semi-quantitative expression of HMGB1 in control
and barn exposed rat lungs. The overall staining was
assigned scores in a blinded manner by using a prede-
termined criterion (Table 1). Compared to controls,
barn-exposed rat lungs showed significantly higher
expression of HMGB1 in bronchiolar epithelium, al-
veolar septa, BALT, endothelium of blood vessels and
ASM (Fig. 2, a-g). In the bronchiolar epithelium,
HMGB1 expression was at the tip of the airway epithe-
lium. In the alveolar septa, type 2 alveolar epithelial
cells showed predominant staining. Type 1 alveolar
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epithelial cells and alveolar macrophages were stained
as well. Since these rat lungs had previously been
lavaged, alveolar macrophages were not in abundance.
Endotoxin content of OD samples
Endotoxin units (EU/mL) measured in OD samples are
presented (Table 4).
EP treatment reduces ODE induced cytoplasmic
expression of HMGB1
We used immunocytochemistry to detect expression of
HMGB1. Using DAPI-stained nuclei as a reference
nucleocytoplasmic translocation of HMGB1 was identi-
fied. Compared to the medium-treated controls,
ODE-treated cells (48 h) showed increased expression
of HMGB1 in the cytoplasm (arrow in merged image,
Fig. 3 a). Compared to vehicle (medium), co-treatment
with EP abrogated the ODE-induced increased expres-
sion of HMGB1 in the cytoplasm (arrow in merged
image, Fig. 3 b).
EP treatment reduces ODE induced HMGB1 expression in
the cytoplasmic fraction
We performed western blotting to quantify the expres-
sion of HMGB1 in nuclear and cytoplasmic fractions of
ODE-treated cells. Compared to controls, ODE expos-
ure increased the HMGB1 protein levels in nuclear (6
and 48 h) and cytoplasmic (6 h) fractions (Fig. 4, a-d).
Compared to the vehicle (medium), co-treatment with
EP significantly reduced the ODE-induced increase in
HMGB1 protein levels in the cytoplasmic fractions at
6 h (Fig. 4, b and d).
ODE exposure results in HMGB1 and RAGE co-localization
We performed immunocytochemistry for evaluating the
expression of HMGB1 and RAGE. Following cell treat-
ments, anti-HMGB1 and anti-RAGE stained (Cy3 and
FITC, respectively) images were merged. Compared to
controls (medium treated, 0 h), ODE-treatment induced an
increase in the expression and co-localization of HMGB1
and RAGE in the cytoplasm (arrow, Fig. 5a, 48 h); both
changes were inhibited by co-treatment with EP. Following
EP treatment, HMGB1 remained arrested in the normal
nuclear location (Fig. 5b, 48 h).
Fig. 3 EP reduces ODE-exposure induced nucleocytoplasmic
translocation of HMGB1. Medium (control, 0 h) or ODE (6, 24 and
48 h post) treated cells were stained with polyclonal anti-HMGB1
antibody and DAPI stain delineated the nuclei. Compared to
controls, ODE treated cells showed nucleocytoplasmic translocation
of HMGB1 (arrows and inset, bar = 200 μm, a). Compared to vehicle
(medium), co-treatment with EP (2.5 μM) showed a marked decrease
in ODE-induced nucleocytoplasmic translocation of HMGB-1 (arrows
and inset, micrometer = 200 μm, b)
Table 4 Endotoxin assay to measure LPS content in the ODE
samples
Sample No. LPS (EU/mL)
1 1.140 ± 0.001
2 0.990 ± 0.0005
3 1.337 ± 0.0006
4 1.433 ± 0.02
5a 1.417 ± 0.002
6b 0.8067 ± 0.0008
7c 1.263 ± 0.0008
aPooled sample from samples 1 and 2
bPooled sample from samples 3 and 4
cPooled sample from samples 1, 2, 3 and 4
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ODE induced ROS and RNS production
We quantified ROS and RNS levels in control and ODE
treated cells to understand the effect of exposure to
ODE in the presence or absence of HMGB1 secretion
(EP treatment). Compared to the controls (medium, 0
h), ODE-treated cells produced significantly higher
amounts of ROS and RNS at 6, 24, and 48 h (Fig. 6, a
and b). Compared to vehicle (medium), co-treatment
with EP significantly reduced ODE-induced ROS (Fig.
6a) but not the RNS production (Fig. 6b).
ODE induced pro-inflammatory cytokines production
We quantified various cytokines in treated cell-supernatants
to understand the effect of ODE in the presence or absence
of HMGB1 secretion (EP treatment). Compared to controls
(medium, 0 h), ODE-treated cells produced significantly
Fig. 4 EP reduces ODE-exposure induced nucleocytoplasmic translocation of HMGB1. Medium (control, 0 h) or ODE (6, 24 and 48 h post) treated
cells were processed for separation of nuclear and cytoplasmic fractions and western blotting to detect HMGB1 protein. Compared to controls,
ODE treated cells showed a temporal increase in HMGB1 expression (25 kD) in the (a) nuclear fraction at 6 and 48 h. Compared to vehicle
(Ringer’s solution), co-treatment with EP (2.5 μM) resulted in significantly decreased levels of HMGB1 in the cytoplasm at 6 h post-treatment
indicating reduction in ODE-induced nucleocytoplasmic translocation of HMGB1 (d). HMGB1 (25kD) bands were normalized over either Lamin B1
(50kD, cytoplasmic fraction, a) or β-actin (37kD, nuclear fraction, b) and percentage intensity (n = 5/group) of treatment groups relative to control
were analyzed using two-way ANOVA (c and d). **p < 0.01 (* indicates difference within the OD/barn exposure groups)
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higher amounts of GM-CSF, IL-1β, IL-8 and IL-6 (p < 0.05,
Fig. 7, a-d). Compared to vehicle (medium), co-treatment
with EP significantly reduced ODE-induced increase in
GM-CSF and IL-1β (Fig. 7, a and b respectively) but not
IL-8 and IL-6 levels.
EP-treatment increases ODE-induced production of
TGF-β1 and IL-10
Compared to controls (medium, 0 h), ODE-treated cells
produced significantly higher amounts of TGF-β1 at 6 and
24 h (Fig. 8). Compared to vehicle (medium), co-treatment
with EP significantly increased the TGF-β1 (24 and 48 h,
Fig. 8a) and IL-10 (6 and 48 h, Fig. 8b) production.
ODE exposure and NF-κB p65 levels
We measured the expression of NF-κB p65 levels in the
whole cell lysates as a read-out of NF-κB activation upon
ODE-exposure (both with and without EP treatment).
Normalized densitometry values revealed no difference
between control and ODE exposed cells with and with-
out EP treatment at 6, 24 and 48 h (Fig. 9).
Treatment with EP or neutralizing anti-HMGB1 antibody
reduces NF-kB p65 nuclear translocation at earlier time
points
We quantified the expression of NF-κB p65 levels in
both nuclear and cytoplasmic fractions to delineate
the NF-κB activation upon ODE-exposure (both with
and without EP or anti-HMGB1 neutralizing anti-
body treatment). Normalized densitometry values re-
vealed that, compared to controls, ODE exposure
increased NF-κB p65 levels in nuclear fractions at 15
and 30 min as well as 1, 1.5, 2 and 3 h. Both EP and
anti-HMGB1 antibody treatments significantly
decreased the ODE-induced increases in NF-κB p65
nuclear levels at 15 min (Fig. 10, a). Compared to
controls, ODE-exposed cells showed increased levels
of NF-κB p65 in the cytoplasm at all the time
points. Both EP and anti-HMGB1 antibody treatment
significantly decreased the levels of NF-κB p65 in
the cytoplasmic fractions at 15 and 30 min as well as
1, 2 and 3 h but not at 1.5 h (Fig. 10, b). EP treated
cells at 1 and 1.5 h still contained higher amounts of
cytoplasmic NF-κB p65 than controls.
Neutralizing anti-HMGB1 antibody treatment reduces ODE
exposure induced secretion of IL-6 but not IL-8 levels
Compared to controls, ODE exposure induced an
increase in GM-CSF, IL-1β, IL-6 and IL-8 levels.
Treatment with neutralizing anti-HMGB1 antibody
significantly decreased IL-6 but not IL-1β or IL-8
levels (Fig. 11, a-d).
Neutralizing ant-HMGB1 antibody treatment augments
ODE-induced production of TGF-β1 and IL-10 levels in
BEAS-2B cells
Compared to controls, treatment of ODE-exposed cells
with anti-HMGB1 neutralizing antibody augmented
Fig. 5 EP reduces ODE-exposure induced augmentation of RAGE
expression and HMGB1-RAGE co-localization in the cytoplasm. Medium
(control, 0 h) or ODE treated (6, 24 and 48 h post) treated cells were
stained with polyclonal anti-HMGB1 or anti-RAGE antibodies. Compared
to controls, ODE treated cells showed increased expression and
nucleocytoplasmic translocation of HMGB1 (arrowhead, 48 h, a),
increased expression of RAGE (48 h, a) and co-localization of HMGB1 and
RAGE (white arrows, 48 h, a). Compared to vehicle (Ringer’s solution), co-
treatment with EP (2.5 μM) resulted in a marked decrease in ODE-
induced nucleocytoplasmic translocation of HMGB-1 and co-localization
of HMGB1 and expression of RAGE (arrows and inset, bar = 200 μm, b)
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Fig. 6 ODE exposure induces ROS and nitrite (secreted RNS) production and EP treatment reduces ODE-induced ROS production. Media alone
(control, 0 h) or ODE (6, 24, and 48 h) treated cells were subjected to CM-H2DCFDA and Griess’ assay to quantify intracellular ROS production
(a) and secreted nitrite concentration (b) respectively (n = 6). ODE exposure of cells resulted in significant increase in intracellular ROS and
nitrite secretion (secreted RNS) into the media as early as 6 h post-treatment. Compared to vehicle treatment, cells co-treated with EP (2.5 μM)
showed a significant reduction in ODE-induced ROS production at 48 h. Data analyzed with two-way ANOVA is represented (a and b). ## or
**p < 0.01 and **** or #### p < 0.0001. # indicates significantly different from control whereas * indicates significant difference within the OD/
barn exposure groups
Fig. 7 EP treatment reduces ODE exposure induced secretion of GM-CSF and IL-1β but not IL-8 and IL-6 levels. Compared to medium
(controls, 0 h), ODE treated BEAS-2B cells secreted increased levels of GM-CSF, IL-1β, IL-8 and IL-6 (a-d) respectively. Compared to vehicle
(Ringer’s solution), co-treatment with EP (2.5 μM) significantly reduced ODE-induced GM-CSF and IL-1β levels (a and b). Data (n = 6) analyzed
using two-way ANOVA is represented. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001, **** or #### p < 0.0001. # indicates different from
control whereas * indicates difference within the OD/barn exposure groups
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the production of TGF-β1 and IL-10 at 6, 24 and 48 h
(Fig. 12, a and b).
Neutralizing anti-HMGB1 antibody treatment reduces
ODE-induced ROS and nitrite production
Compared to controls, ODE exposure induced signifi-
cant production of intracellular ROS and secreted ni-
trite (representing RNS). Treatment with neutralizing
anti-HMGB1 antibody significantly decreased the
intracellular ROS (48 h) and secreted nitrite levels (6
and 48 h, Fig. 13, a and b respectively).
ODE exposure modulates NF-κB subunit gene expression
with time
Compared to controls, ODE-exposed cells showed in a
significant increase in the transcripts of NF-κB sub units
namely, nf-κbp65, nf-κbp52 and crel at 6, 24 and 48 h but
not nf-κbp50 and relb (Fig. 14, a-e respectively).
ODE exposure increases tlr2 and tlr4 expression
Compared to controls, ODE exposed cells showed a sig-
nificant increase in the transcripts of tlr2 and tlr4 at 6,
24 and 48 h (Fig. 15, a and b).
Fig. 8 EP-treatment augments ODE-induced production of TGF-β1 and IL-10 levels in BEAS-2B cells. Compared to medium (control,
0 h), co-treatment of ODE exposed BEAS-2B cells with EP (2.5 μM) significantly increased the production of TGF-β1 (24 and 48 h) and
IL-10 (6, 24 and 48 h).d Data (n = 6) analyzed with two-way ANOVA is represented. * or #p < 0.05, ** or ##p < 0.01, *** or ### p < 0.001,
**** or #### p < 0.0001. # indicates different from control whereas * indicates difference within the OD/barn exposure groups
Fig. 9 ODE exposure with or without EP-treatment does not alter - NF-κB p65 levels. Medium or ODE treated (with or without co-treatment with EP)
whole cell fractions were processed for western blot analysis of NF-κB p65 and β-actin proteins (a). Normalized intensity values (as percentage relative to
controls) were compared (b). There was no difference between any of the treatment groups. Data (n= 5) analyzed with one-way ANOVA is represented
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Fig. 10 (See legend on next page.)
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Discussion
Persistent exposure to OD is the hallmark of occupa-
tional respiratory diseases of agriculture production
workers as well as in other industries. Early acute symp-
toms of airway inflammation dampen over a period of
continued exposure, but long-term lung remodeling fea-
tures and loss of lung function is evident [2, 9]. Unraveling the
cell and molecular basis of how low-grade inflammation drives
the chronic exposure induced changes may result in better
therapies. In this study, we show that OD-exposure of human
airway epithelial cells induces nucleocytoplasmic translocation
of HMGB1. EP or anti-HMGB1 neutralizing antibody treat-
ment reduces OD-induced inflammation via targeting
HMGB1-RAGE pathway.
First, using our well characterized rat model of OD
(swine barn) exposure [15], we demonstrated that barn
exposure increases expression of HMGB1 in the lung
tissue compartments. This indicates that HMGB1 has a
possible role in OD-induced lung inflammation and air-
way reactivity. Other researchers have shown that in-
creased expression of HMGB1 in the airway epithelium
leads to pulmonary fibrosis [44] as well as epithelial
mesenchymal transition via TGF-β (reviewed in [44,
45]). Next, increased expression of HMGB1 in the lung
ASM observed in our study assumes importance since it
is known to contribute to ASM dysfunction in a human
asthma model [27]. Increased expression of HMGB1 in
the blood vessels of the lung is known to cause pulmon-
ary artery hypertension [46] and has a role in ischemia
induced blood-brain barrier disruption [47] . Increased
expression of HMGB1 in BALT is interesting since
HMGB1 is considered to be a central cytokine for all
Fig. 11 Neutralizing anti-HMGB1 antibody treatment reduces ODE exposure induced secretion of IL-6 but not IL-8 levels. Compared to controls,
ODE treatment increased the production of GM-CSF (a, 24 and 48 h), IL-1β, IL-6 and IL-8. When ODE exposed cells were treated with anti-HMGB1
antibody (10 μM), significantly reduced ODE-induced increase in IL-6 levels only (c). and did not change GM-CSF (a), IL-1β (b) and IL-8 (d) levels.
Data (n = 6) analyzed using two-way ANOVA is represented. ** or ## p < 0.01 and **** or #### p < 0.0001. # indicates different from control
whereas * indicates difference within the OD/barn exposure groups
(See figure on previous page.)
Fig. 10 Treatment with EP or anti-HMGB1 neutralizing antibody decreases NF-kB p65 nuclear translocation Cells were processed for separation of
nuclear and cytoplasmic fractions and western blotting to detect NF-κBp65 protein. Compared to controls, ODE treated cells showed a temporal
increase in NF-κB p65 expression (68 kDa) in the (a) nuclear fraction at 15 min. Compared to vehicle (medium), co-treatment with EP and anti-
HMGB1 antibody (10 μM) resulted in significant decrease in the levels of NF-κB p65 in the cytoplasm at 15 min post-treatment indicating
reduction in ODE-induced NFκB p65 activation (b and d). NF-κB p65 (68 kD) bands were normalized over either Lamin B1 (50 kD, nuclear fraction,
a) or β-actin (37 kD, cytoplasmic fraction, b) and percentage intensity (n = 5/group) values of treatment groups relative to control were analyzed
using two-way ANOVA (c and d). * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001, **** or #### p < 0.0001. # indicates different from control
whereas * indicates difference within the OD/barn exposure groups
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lymphoid cells [48]. Increased expression of HMGB1 in
the BALT partly explains our previous observation in
the same rat model that a 20-day barn exposure induces
activation of BALT [15]. Taken together, increased ex-
pression of HMGB1 in the lung following 1, 5, and
20-day barn exposure indicates the potential patho-
logical role of this secreted DAMP molecule.
Using in vitro model of human airway exposure to OD,
we now demonstrate nucleocytoplasmic translocation of
HMGB1, increased expression as well as cytoplasmic
co-localization of HMGB1 with RAGE in the cytoplasm. In-
stead of normal nuclear location, accumulation of HMGB1
in the cytoplasm indicates cellular stress and cytoplasmic
HMGB1 is a chief regulator of autophagy [49]. Secreted
HMGB1 is known to potentiate inflammation in the pres-
ence of PAMPs such as LPS [50]. Our results indicate that
ODE-exposure induced HMGB1 accumulation in the cyto-
plasm and secretion into extracellular compartment particu-
larly in chronic exposure to OD may drive aberrant airway
inflammation and lead to lung remodeling features [50].
Although, our efforts to quantify secreted HMGB1 were not
fully successful, we did observe higher molecular weight
bands for secreted HMGB1 in the cell culture supernatant
(data not shown). Posttranslational modifications such
as acetylation and oxidation of HMGB1 may have
contributed to this higher molecular weight HMGB1.
Currently, few laboratories have expertise and estab-
lished methods to measure secreted HMGB1 with
post-translational modification/s.
Immunocytochemistry showed co-localization of
HMGB1 and RAGE in the cytoplasm indicated possible
physical interaction of HMGB1 with its main receptor
RAGE. To our knowledge, this is possibly the first report
of secretion of DAMP in an in vitro model of human
airway epithelial cell exposure to OD and co-localization
of HMGB1 with RAGE. It is likely that increased expres-
sion and secretion of HMGB1 (cytoplasmic and extracel-
lular) may be driving a sustained inflammation in
long-term OD-exposed individuals via HMGB1-RAGE
signaling.
Fig. 13 Antibody neutralization treatment reduces ODE-induced ROS and nitrite production. Cells or supernatants were subjected to CM-H2DCFDA
and Griess’ assay to quantify intracellular ROS production (a) and secreted nitrite concentration (b) respectively (n = 6). Compared to ODE exposure
alone, ODE exposed cells co-treated with Anti-HMGB1 antibody (10 μM) showed a significant reduction in ODE-induced ROS production (48 h) and
secreted nitrite (6 and 48 h). Data analyzed with two-way ANOVA is represented (a and b). * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001, **** or
#### p < 0.0001. # indicates different from control whereas * indicates difference within the OD/barn exposure groups
Fig. 12 Neutralizing antibody treatment augments ODE-induced production of TGF-β1 and IL-10 levels in BEAS-2B cells. Compared to medium
(control, 0 h), co-treatment of ODE exposed BEAS-2B cells with Anti-HMGB1 antibody (10 μM) significantly increased the production of TGF-β1 (a,
6, 24 and 48 h) and IL-10 (b, 6, 24 and 48 h). Data (n = 6) analyzed with two-way ANOVA is represented. * or # p < 0.05, ** or ## p < 0.01, *** or
### p < 0.001, **** or #### p < 0.0001. # indicates different from control whereas * indicates difference within the OD/barn exposure groups
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Next, using EP treatment we were able to abrogate
ODE-induced nucleocytoplasmic translocation of
HMGB1. EP treatment also decreased the expression and
co-localization of HMGB1 and RAGE in the cytoplasm.
EP is known to prevent phosphorylation of HMGB1 by
chelating calcium and thereby prevents nucleocytoplasmic
translocation of HMGB1 [36]. Other post-translational
modifications such as acetylation have been shown to be
important for nucleocytoplasmic translocation of HMGB1
[51]. Our study did not examine if any of the posttransla-
tional modification were involved in OD-induced
translocation of HMGB1. Our central focus was to exam-
ine if nucleocytoplasmic translocation and secretion of
HMGB1 would be influencing OD-induced airway
inflammation.
We have demonstrated that ODE exposure of airway
epithelium results in ROS and RNS production. When
we arrested nucleocytoplasmic translocation of HMGB1
using EP treatment, we observed significantly decreased
levels of ROS but not RNS. It is interesting to note that,
ODE exposure increased the ROS levels at 24 and 48 h
whereas RNS production was significantly higher
Fig. 14 ODE exposure modulates NF-κB subunit gene expression with time. qRT-PCR analysis on NF-κB sub unit genes was performed on control and
ODE exposed cells at 6, 24 and 48 h (a-3). Compared controls, ODE-exposure induced a significant increase in nfkbp65 (a), nfkbp52 (b) and crel (d) at 6,
24 and 48 h (#, p < 0.05 and ###, p < 0.001 with respect to controls) and did not change nfkbp50 (c) and relb (e). Data analyzed with one-way ANOVA is
represented as fold change of mRNA expression shown relative to untreated control cells
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starting from 6 h onwards. Based on our results, it is
possible that ODE-induced translocation of HMGB1 has
a role in potentiating ROS but not RNS levels. This is
again supported by the fact that EP mediated arrest of
HMGB1 translocation did not affect ODE-induced RNS
levels at all the time points. Though we do not provide
direct mechanistic evidences, these results pave way for
further investigation.
To examine if HMGB1 translocation had any effect on
inflammatory mediators, we measured the levels of
GM-CSF, IL-1β and IL-6 (pro-inflammatory), TGF-β1
(pleiotropic cytokine) and IL-10 (anti-inflammatory) and
IL-8 (neutrophil chemokine). ODE-exposure increased
the levels of GM-CSF, IL-1β, IL-6 and IL-8. Secretion of
GM-CSF by airway epithelial cells is important since it is
known to sensitize the airway epithelium to allergic in-
sults such as house dust mite or cockroach allergen [52].
Further, GM-CSF in an inflammatory tissue milieu
which acts as a link between recruited lymphocytes and
monocytes and could be targeted to reduce chronic in-
flammation [53]. Next, our observation of increase in
IL-1β production is consistent with published work on
BEAS-2B cells exposed to poultry barn dust extract [54].
IL-1β has a variety of inflammatory effects in the lung
including induction of airway hyper responsiveness [55,
56]. ODE-induced IL-6 production assumes significance
since the recent work has identified IL-6 as an important
link in lung-bone inflammatory axis in a mouse model
of intra-nasal ODE exposure [21]. Next, IL-8 secretion
observed in our study is in line with other published evi-
dences [57, 58]. IL-8 is known to attract neutrophils to
the site of inflammation and neutrophilic oxidative stress
upon exposure to OD is known to drive pulmonary in-
flammation and airway reactivity [59]. Using a specific
antagonist against IL-8 was beneficial in an OD-induced
lung inflammation model [60].
Lastly, we demonstrated that EP-treatment augments
IL-10 and TGF-β production in ODE-exposed airway
epithelial cells. Production of IL-10 generally results in
anti-inflammatory effects (reviewed in [61]). Airway epi-
thelial cell derived TGF-β is important in driving type 2
innate lymphoid cell responses to allergens and TGF-β
is known to exacerbate house dust mite-induced path-
ology and increased expression of TGF-β is seen with viral
and allergen challenge (reviewed in [62]). Taken together,
upon ODE exposure, human airway epithelial cells secrete
a variety of inflammatory mediators.
Our unique observation that EP treatment had no effect
on the ODE-induced IL-8 and IL-6 indicates several possi-
bilities. First, HMGB1 mediated signaling pathway as well
as ODE-induced IL-8/IL-6 secretion may be independent
of each other. Second, IL-8 and IL-6 production peaks
from 6 h after ODE-exposure and it is likely that secreted
HMGB1 acts at a later time point to potentiate the inflam-
mation. Although we do not provide any direct evidence,
there is a link between decrease in cytoplasmic/secreted
HMGB1 levels following EP treatment and decrease in
ODE-induced GM-CSF and IL-1β levels. This again high-
lights the fact that HMGB1 is a late-player in many in-
flammatory events (reviewed in [63]).
In order to examine mechanistically, if arrest of nucleo-
cytoplasmic translocation of HMGB1 reduces inflamma-
tory mediators through NF-κB, immunoblots for NF-κB
p65 in control (0 h) and ODE exposure (6, 24 and 48 h)
with media or EP treatments revealed no significant differ-
ence between any of the groups (all time points). However,
when we probed the NF-κB p65 levels in the nuclear and
cytoplasmic fractions at early time points, we found that
Fig. 15 ODE exposure increases tlr2 and tlr4 gene expression with time.
qRT-PCR analysis on tlr2 (a) and tlr4 (b) genes was performed on control
and ODE exposed cells at 6, 24 and 48 h. Compared to controls, ODE
exposure resulted in a significant increase in fold in the expression of
both tlr2 and tlr4 (###, p< 0.001 and ####, p < 0.0001, a and b
respectively). Data analyzed with one-way ANOVA is represented as fold
change of mRNA expression shown relative to untreated control cells
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ODE exposure increases both nuclear and cytoplasmic
levels of NF-κB p65 as early as 15min. Both EP and
anti-HMGB1 antibody treatments significantly reduced
NF-κB p65 levels in both nucleus and cytoplasm indicat-
ing that their anti-inflammatory action is via a reduction
in the translocation of NF-κB p65.
We and others have previously shown the roles of TLR2
[18] and TLR4 [16] in OD exposure induced lung inflam-
mation. We now show significant increase in the expres-
sion of tlr2 and tlr4 genes following ODE exposure. We
observed translocation of NF-κB p65 into the nucleus as
early as 15min indicating that ODE-induced innate sig-
naling via TLR2 and 4 results in NF-κB activation leading
to cytokine secretion. However, both EP and anti-HMGB1
antibody treatments inhibited both nuclear translocation
of NF-κB p65 and pro-inflammatory cytokine production
to highlight the importance of targeting HMGB1. Since
pharmacological tool blocking HMGB1 translocation and
RAGE expression (EP) or genetic tool suppressing the ex-
pression of HMGB1 is able to reduce ODE-induced in-
flammation, HMGB1 signaling is a major driver of
ODE-induced airway inflammation. Though our study has
not investigated the specific downstream events in this
pathway, EP or anti-HMGB1 antibody mediated targeting
of HMGB1-RAGE pathway is promising.
Conclusions
OD exposure of human airway epithelial cell line results
in the nucleocytoplasmic translocation of HMGB1, cyto-
plasmic co-localization of HMGB1 with RAGE as well
as production of ROS, RNS and inflammatory cytokines.
EP or anti-HMGB1 antibody treatment abrogates OD
exposure induced translocation of HMGB1 and many
inflammatory end-points. Therefore, HMGB1-RAGE
signaling is an attractive target to treat OD-induced oc-
cupational lung diseases.
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